New medicine for house dust mite allergic rhinitis now available in Japan
Copenhagen, Nov. 25, 2015 (GLOBE NEWSWIRE) -- ALK ( ALKB:DC / OMX: ALK B / AKABY / AKBLF) today announced that the sublingual allergy immunotherapy product MITICURE(tm) now will be available for prescription in Japan for adults and adolescents (12-64 years …